株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

米国の心調律管理、電気生理学、心臓アブレーション市場 (2019~2025年)

Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite

発行 iData Research Inc. 商品コード 915024
出版日 ページ情報 英文 518 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

Back to Top
米国の心調律管理、電気生理学、心臓アブレーション市場 (2019~2025年) Cardiac Rhythm Management Market Analysis, Size, Trends | United States | 2019-2025 | MedSuite
出版日: 2019年08月03日 ページ情報: 英文 518 Pages
概要

2018年、米国の心調律管理、電気生理学、心臓アブレーション市場は大きく拡大しました。これらは救命器具であり、米国の高齢化もあいまって、同市場のすべてのセグメントで拡大を続けています。

当レポートでは、米国の心調律管理、電気生理学、心臓アブレーション市場について調査し、市場の動向とセグメント別動向、国別予測、製品ポートフォリオについてまとめています。

第1章 調査方法

第2章 疾患概要

  • 疾患の治療と診断
  • 不整脈のタイプ
  • 心不全
  • 心臓発作
  • 患者人口統計

第3章 製品評価

  • イントロダクション
  • 製品ポートフォリオ
    • ペースメーカー
    • ICD
    • CRT機器
    • 心臓リード
    • 体外除細動器
    • ラボシステム
    • 診断用EPカテーテル
    • 心臓アブレーションカテーテル
  • FDAリコール
  • 治験

第4章 米国の心調律管理、電気生理学、心臓アブレーション市場概要

  • イントロダクション
  • 市場概要
  • セグメント別動向分析
  • 促進因子と制限因子
  • 競合市場シェア分析
  • 合併・買収
  • 企業プロファイル
  • SWOT分析

第5章 手技件数

第6章 ペースメーカー市場

第7章 ICD市場

第8章 CRT機器市場

第9章 心臓リード市場

第10章 心電計モニタリング市場

第11章 ラボシステム市場

第12章 診断用電気生理学カテーテル市場

第13章 心臓アブレーションカテーテル市場

図表

LIST OF CHARTS

  • Chart 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025 3
  • Chart 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Overview, U.S., 2018 & 2025 3
  • Chart 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025 149
  • Chart 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2018 150
  • Chart 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Breakdown, U.S., 2025 151
  • Chart 4 4: Growth Rates by Segment, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2016 - 2025 155
  • Chart 4 5: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 166
  • Chart 5 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 - 2025 193
  • Chart 6 1: Pacemaker Market by Segment, U.S., 2015 - 2025 199
  • Chart 6 2: Pacemaker Market Breakdown, U.S., 2018 200
  • Chart 6 3: Pacemaker Market Breakdown, U.S., 2025 201
  • Chart 6 4: Total Pacemaker Market, U.S., 2015 - 2025 203
  • Chart 6 5: Single-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025 206
  • Chart 6 6: Total Single-Chamber Pacemaker Market, U.S., 2015 - 2025 208
  • Chart 6 7: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 - 2025 210
  • Chart 6 8: Replacement Single-Chamber Pacemaker Market, U.S., 2015 - 2025 212
  • Chart 6 9: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025 215
  • Chart 6 10: Total Dual-Chamber Pacemaker Market, U.S., 2015 - 2025 217
  • Chart 6 11: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025 219
  • Chart 6 12: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025 221
  • Chart 6 13: Leadless Pacemaker Market, U.S., 2015 - 2025 224
  • Chart 6 14: Leading Competitors, Pacemaker Market, U.S., 2018 232
  • Chart 7 1: ICD Market by Segment, U.S., 2015 - 2025 236
  • Chart 7 2: ICD Market Breakdown, U.S., 2018 237
  • Chart 7 3: ICD Market Breakdown, U.S., 2025 238
  • Chart 7 4: Total ICD Market, U.S., 2015 - 2025 240
  • Chart 7 5: Single-Chamber ICD Market by Segment, U.S., 2015 - 2025 243
  • Chart 7 6: Total Single-Chamber ICD Market, U.S., 2015 - 2025 245
  • Chart 7 7: Initial Placement Single-Chamber ICD Market, U.S., 2015 - 2025 247
  • Chart 7 8: Replacement Single-Chamber ICD Market, U.S., 2015 - 2025 249
  • Chart 7 9: Dual-Chamber ICD Market by Segment, U.S., 2015 - 2025 252
  • Chart 7 10: Total Dual-Chamber ICD Market, U.S., 2015 - 2025 254
  • Chart 7 11: Initial Placement Dual-Chamber ICD Market, U.S., 2015 - 2025 256
  • Chart 7 12: Replacement Dual-Chamber ICD Market, U.S., 2015 - 2025 258
  • Chart 7 13: S-ICD Market, U.S., 2015 - 2025 261
  • Chart 7 14: Leading Competitors, ICD Market, U.S., 2018 268
  • Chart 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 - 2025 272
  • Chart 8 2: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2018 273
  • Chart 8 3: Cardiac Resynchronization Therapy Device Market Breakdown, U.S., 2025 274
  • Chart 8 4: Total CRT Market, U.S., 2015 - 2025 277
  • Chart 8 5: CRT-P Market by Segment, U.S., 2015 - 2025 279
  • Chart 8 6: Total CRT-P Market, U.S., 2015 - 2025 281
  • Chart 8 7: Initial Placement CRT-P Market, U.S., 2015 - 2025 283
  • Chart 8 8: Replacement CRT-P Market, U.S., 2015 - 2025 285
  • Chart 8 9: CRT-D Market by Segment, U.S., 2015 - 2025 287
  • Chart 8 10: Total CRT-D Market, U.S., 2015 - 2025 289
  • Chart 8 11: Initial Placement CRT-D Market, U.S., 2015 - 2025 291
  • Chart 8 12: Replacement CRT-D Market, U.S., 2015 - 2025 293
  • Chart 8 13: Leading Competitors, CRT Market, U.S., 2018 301
  • Chart 9 1: Cardiac Lead Market by Segment, U.S., 2015 - 2025 305
  • Chart 9 2: Cardiac Lead Market Breakdown, U.S., 2018 306
  • Chart 9 3: Cardiac Lead Market Breakdown, U.S., 2025 307
  • Chart 9 4: Total Cardiac Lead Market, U.S., 2015 - 2025 309
  • Chart 9 5: Pacing Lead Market, U.S., 2015 - 2025 311
  • Chart 9 6: Defibrillation Lead Market, U.S., 2015 - 2025 313
  • Chart 9 7: LV Lead Market, U.S., 2015 - 2025 315
  • Chart 9 8: Leading Competitors, Cardiac Lead Market, U.S., 2018 322
  • Chart 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 - 2025 326
  • Chart 10 2: Electrocardiography Monitoring Market Breakdown, U.S., 2018 327
  • Chart 10 3: Electrocardiography Monitoring Market Breakdown, U.S., 2025 328
  • Chart 10 4: Resting ECG Device Market by Segment, U.S., 2015 - 2025 330
  • Chart 10 5: Total Resting ECG Device Market, U.S., 2015 - 2025 332
  • Chart 10 6: Hospital-Based Resting ECG Device Market, U.S., 2015 - 2025 334
  • Chart 10 7: Office-Based Resting ECG Device Market by Segment, U.S., 2015 - 2025 336
  • Chart 10 8: Total Office-Based Resting ECG Device Market, U.S., 2015 - 2025 338
  • Chart 10 9: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 - 2025 340
  • Chart 10 10: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 - 2025 342
  • Chart 10 11: Stress Testing Device Market by Segment, U.S., 2015 - 2025 345
  • Chart 10 12: Total Stress Testing Device Market, U.S., 2015 - 2025 347
  • Chart 10 13: Hospital-Based Stress Testing Device Market, U.S., 2015 - 2025 349
  • Chart 10 14: Office-Based Stress Testing Device Market, U.S., 2015 - 2025 351
  • Chart 10 15: Holter Monitoring Recorder Market by Segment, U.S., 2015 - 2025 354
  • Chart 10 16: Total Holter Monitoring Recorder Market, U.S., 2015 - 2025 356
  • Chart 10 17: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025 358
  • Chart 10 18: Office-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025 360
  • Chart 10 19: IDTF Holter Monitoring Recorder Market, U.S., 2015 - 2025 362
  • Chart 10 20: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018 369
  • Chart 11 1: Lab Systems Market by Segment, U.S., 2015 - 2025 374
  • Chart 11 2: Lab Systems Market Breakdown, U.S., 2018 375
  • Chart 11 3: Lab Systems Market Breakdown, U.S., 2025 376
  • Chart 11 4: 3D Mapping Market, U.S., 2015 - 2025 378
  • Chart 11 5: EP Recording Market, U.S., 2015 - 2025 380
  • Chart 11 6: RF Ablation Generator Market, U.S., 2015 - 2025 382
  • Chart 11 7: Remote Steering System Market, U.S., 2015 - 2025 384
  • Chart 11 8: Leading Competitors, Lab Systems Market, U.S., 2018 391
  • Chart 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 - 2025 395
  • Chart 12 2: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2018 396
  • Chart 12 3: Diagnostic Electrophysiology Catheters Market Breakdown, U.S., 2025 397
  • Chart 12 4: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 - 2025 400
  • Chart 12 5: EP Conventional Catheter Market by Segment, U.S., 2015 - 2025 403
  • Chart 12 6: Total EP Conventional Catheter Market, U.S., 2015 - 2025 405
  • Chart 12 7: Fixed EP Catheter Market, U.S., 2015 - 2025 407
  • Chart 12 8: Steerable EP Catheter Market, U.S., 2015 - 2025 409
  • Chart 12 9: EP Advanced Catheter Market, U.S., 2015 - 2025 411
  • Chart 12 10: ICE Diagnostic Catheter Market, U.S., 2015 - 2025 414
  • Chart 12 11: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018 421
  • Chart 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 - 2025 425
  • Chart 13 2: Cardiac Ablation Catheter Market Breakdown, U.S., 2018 426
  • Chart 13 3: Cardiac Ablation Catheter Market Breakdown, U.S., 2025 427
  • Chart 13 4: Cardiac Ablation Catheter Market, U.S., 2015 - 2025 429
  • Chart 13 5: RF Ablation Market by Segment, U.S., 2015 - 2025 432
  • Chart 13 6: Total RF Ablation Catheter Market, U.S., 2015 - 2025 434
  • Chart 13 7: Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025 436
  • Chart 13 8: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025 438
  • Chart 13 9: Cryoablation Catheter Market, U.S., 2015 - 2025 440
  • Chart 13 10: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018 447
  • Chart 14 1: ICE Generator Market, U.S., 2015 - 2025 450
  • Chart 14 2: Leading Competitors, ICE Generator Market, Europe, 2018 456
  • Chart 15 1: Cryoablation Generator Market, U.S., 2015 - 2025 459
  • Chart 16 1: External Defibrillator Market by Segment, U.S., 2015 - 2025 468
  • Chart 16 2: External Defibrillator Market Breakdown, U.S., 2018 469
  • Chart 16 3: External Defibrillator Market Breakdown, U.S., 2025 470
  • Chart 16 4: Total External Defibrillator Market, U.S., 2015 - 2025 473
  • Chart 16 5: Automated External Defibrillator Market, U.S., 2015 - 2025 475
  • Chart 16 6: Wearable Cardioverter Defibrillator Market, U.S., 2015 - 2025 477
  • Chart 16 7: Leading Competitors, External Defibrillator Market, U.S., 2018 483

LIST OF FIGURES

  • Figure 1 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (1 of 2) 5
  • Figure 1 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Share Ranking by Segment, U.S., 2018 (2 of 2) 5
  • Figure 1 3: Companies Researched in this Report 6
  • Figure 1 4: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (1 of 2) 7
  • Figure 1 5: Factors Impacting the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S. (2 of 2) 8
  • Figure 1 6: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2018 (1 of 3) 9
  • Figure 1 7: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2018 (2 of 3) 10
  • Figure 1 8: Recent Events in the Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, 2015 - 2018 (3 of 3) 11
  • Figure 1 9: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures Covered 12
  • Figure 1 10: Procedure Codes Investigated 12
  • Figure 1 11: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (1 of 2) 13
  • Figure 1 12: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Markets Covered, (2 of 2) 14
  • Figure 1 13: Key Report Updates 15
  • Figure 1 14: Version History 15
  • Figure 3 1: Pacemaker Market Products by Company 47
  • Figure 3 2: ICD Market Products by Company 49
  • Figure 3 3: CRT Device Market Products by Company 51
  • Figure 3 4: Cardiac Leads Market Products by Company 53
  • Figure 3 5: External Defibrillator Market Products by Company 55
  • Figure 3 6: Lab Systems Market Products by Company 60
  • Figure 3 7: Diagnostic EP Catheter Market Products by Company 64
  • Figure 3 8: Cardiac Ablation Catheter Products by Company (1 of 2) 68
  • Figure 3 9: Cardiac Ablation Catheter Products by Company (2 of 2) 69
  • Figure 3 10: Class 2 Device Recall Assurity 70
  • Figure 3 11: Class 2 Device Recall Zenex 70
  • Figure 3 12: Class 2 Device Recall Accent family of pacemakers 70
  • Figure 3 13: Class 1 Device Recall Fortify, Fortify Assura 71
  • Figure 3 14: Class 1 Device Recall Fortify, Unify, Assura, including Quadra 71
  • Figure 3 15: Class 2 Device Recall Ellipse 72
  • Figure 3 16: Class 2 Device Recall Allure Quadra 72
  • Figure 3 17: Class 2 Device Recall Anthem, Allure 72
  • Figure 3 18: Class 2 Device Recall Nuance 73
  • Figure 3 19: Class 1 Device Recall Optisure HV lead 73
  • Figure 3 20: Class 3 Device Recall FIRMap 60mm Catheter 73
  • Figure 3 21: Class 2 Device Recall TactiSys Quartz Pack, PN004 400 74
  • Figure 3 22: Class 2 Device Recall SMARTABLATE RF Generator System 75
  • Figure 3 23: Class 2 Device Recall ESSENTIO Pacemaker 76
  • Figure 3 24: Class 2 Device Recall PROPONENT Pacemaker 76
  • Figure 3 25: Class 2 Device Recall ACCOLADE Pacemaker 76
  • Figure 3 26: Class 2 Device Recall PROPONENT SR Pacemaker 77
  • Figure 3 27: Class 2 Device Recall PROPONENT DR Pacemaker 77
  • Figure 3 28: Class 2 Device Recall PROPONENT EL DR Pacemaker 77
  • Figure 3 29: Class 2 Device Recall PROPONENT VDD SL Pacemaker 77
  • Figure 3 30: Class 2 Device Recall PROPONENT VDD SL Pacemaker 78
  • Figure 3 31: Class 2 Device Recall ACCOLADE MRI EL DR Pacemaker 78
  • Figure 3 32: Class 2 Device Recall ACCOLADE MRI DR Pacemaker 78
  • Figure 3 33: Class 2 Device Recall ACCOLADE MRI SR Pacemaker 78
  • Figure 3 34: Class 2 Device Recall ACCOLADE EL DR Pacemaker 79
  • Figure 3 35: Class 2 Device Recall ACCOLADE DR Pacemaker 79
  • Figure 3 36: Class 2 Device Recall ACCOLADE SR Pacemaker 79
  • Figure 3 37: Class 2 Device Recall ESSENTIO MRI EL DR Pacemaker 79
  • Figure 3 38: Class 2 Device Recall ESSENTIO MRI DR Pacemaker 80
  • Figure 3 39: Class 2 Device Recall ESSENTIO MRI SR Pacemaker 80
  • Figure 3 40: Class 2 Device Recall ESSENTIO DR Pacemaker 80
  • Figure 3 41: Class 2 Device Recall ESSENTIO SR Pacemaker 80
  • Figure 3 42: Class 2 Device Recall ALTRUA 2 EL DR Pacemaker 81
  • Figure 3 43: Class 2 Device Recall ALTRUA 2 SR Pacemaker 81
  • Figure 3 44: Class 2 Device Recall ALTRUA 2 DR Pacemaker 81
  • Figure 3 45: Class 2 Device Recall Accolade MRI and Essentio MRI pacemakers 81
  • Figure 3 46: Class 2 Device Recall Implantable Cardioverter Defibrillator (NonCRT) 82
  • Figure 3 47: Class 2 Device Recall RESONATE EL ICD VR 82
  • Figure 3 48: Class 2 Device Recall RESONATE EL ICD DR 82
  • Figure 3 49: Class 2 Device Recall EMBLEM SICD, Model A209 82
  • Figure 3 50: Class 2 Device Recall SQRX 1010 Pulse Generator 83
  • Figure 3 51: Class 2 Device Recall EMBLEM MRI SICD Model 219 83
  • Figure 3 52: Class 2 Device Recall SQRX Model 1010 Subcutaneous Pulse Generator 83
  • Figure 3 53: Class 2 Device Recall VISIONIST X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) 83
  • Figure 3 54: Class 2 Device Recall VALITUDE X4 CRTP (Cardiac Resynchronization Therapy Pacemaker) 84
  • Figure 3 55: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker 84
  • Figure 3 56: Class 2 Device Recall VALITUDE CRTP Pacemaker 84
  • Figure 3 57: Class 2 Device Recall VISIONIST X4 CRTP Pacemaker 84
  • Figure 3 58: Class 2 Device Recall VISIONIST CRTP Pacemaker 85
  • Figure 3 59: Class 2 Device Recall VALITUDE X4 CRTP Pacemaker 85
  • Figure 3 60: Class 2 Device Recall RESONATE X4 CRTD 85
  • Figure 3 61: Class 2 Device Recall MOMENTUM X4 CRTD 85
  • Figure 3 62: Class 2 Device Recall VIGILANT X4 CRTD 86
  • Figure 3 63: Class 2 Device Recall Boston Scientific, INGEVITY MRI Leads, Sterile EO, RxOnly 86
  • Figure 3 64: Class 2 Device Recall Maestro 4000 Cardiac Ablation System 86
  • Figure 3 65: Class 2 Device Recall CLEARSIGN II Amplifier for LABSYSTEM PRO EP Recording System 87
  • Figure 3 66: Class 3 Device Recall Cardiac Ablation Percutaneous Catheters 87
  • Figure 3 67: Class 1 Device Recall Intella Tip MiFi Open Irrigated Ablation Catheter 87
  • Figure 3 68: Class 2 Device Recall 9131 Defibrillator Electrodes 88
  • Figure 3 69: Class 2 Device Recall Medtronic Model 53401 Single Chamber External Pulse Generator 89
  • Figure 3 70: Class 2 Device Recall Medtronic Model 5392 Dual Chamber Temporary External Pulse Generator 89
  • Figure 3 71: Class 2 Device Recall EnTrust Dual Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies 90
  • Figure 3 72: Class 2 Device Recall EnTrust Single Chamber Implantable Cardioverter Defibrillator with Atrial and Ventricular Therapies 90
  • Figure 3 73: Class 2 Device Recall Medtronic EnTrust Escudo 91
  • Figure 3 74: Class 1 Device Recall Evera MRI XT DR ICD, Evera MRI XT VR ICD, Evera MRI S DR ICD 91
  • Figure 3 75: Class 1 Device Recall Visia AF MRI VR SureScan ICD 91
  • Figure 3 76: Class 1 Device Recall Visia AF VR ICD 92
  • Figure 3 77: Class 1 Device Recall Evera S DR ICD, Evera S VR ICD, Evera XT DR ICD, Evera XT VR ICD 92
  • Figure 3 78: Class 2 Device Recall Evera ICD 92
  • Figure 3 79: Class 2 Device Recall Viva ICD 93
  • Figure 3 80: Class 2 Device Recall Percepta CRTP MRI SureScan 93
  • Figure 3 81: Class 2 Device Recall Percepta Quad CRTP MRI SureScan 93
  • Figure 3 82: Class 1 Device Recall Amplia MRI CRTD, Amplia MRI Quad CRTD 94
  • Figure 3 83: Class 1 Device Recall Viva Quad S CRTD, Viva Quad XT CRTD, Viva S CRTD, Viva XT CRTD 94
  • Figure 3 84: Class 1 Device Recall Compia MRI CRTD, Compia MRI Quad CRTD 95
  • Figure 3 85: Class 2 Device Recall Amplia MRI Quad CRT0 SureScanClaria MRI Quad CRTD SureScanCompia MRI Quad CRTD SureScan 95
  • Figure 3 86: Class 2 Device Recall InSync III 95
  • Figure 3 87: Class 2 Device Recall Medtronic, Temporary Pacing Lead System 96
  • Figure 3 88: Class 2 Device Recall Achieve Electrical Cable 96
  • Figure 3 89: Class 2 Device Recall Medtronic CryoConsole 96
  • Figure 3 90: Class 2 Device Recall Platinium DR 1510 97
  • Figure 3 91: Class 2 Device Recall Platinium VR 1210 97
  • Figure 3 92: Class 2 Device Recall Platinium DR DF4 1540 97
  • Figure 3 93: Class 2 Device Recall Platinium VR DF4 1240 98
  • Figure 3 94: Class 2 Device Recall PARADYM 98
  • Figure 3 95: Class 2 Device Recall OVATIO 98
  • Figure 3 96: Class 2 Device Recall INTENSIA 98
  • Figure 3 97: Class 2 Device Recall Platinium Implantable Cardiac Defibrillator and Resynchronization Therapy Defibrillator 99
  • Figure 3 98: Class 2 Device Recall Platinium CRTD 1741 99
  • Figure 3 99: Class 2 Device Recall Platinium CRT DF1 1711 99
  • Figure 3 100: Class 2 Device Recall PARADYM 100
  • Figure 3 101: Class 2 Device Recall OVATIO 100
  • Figure 3 102: Class 2 Device Recall INTENSIA 100
  • Figure 3 103: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator 101
  • Figure 3 104: Class 2 Device Recall Philips HeartStart FRx AED 101
  • Figure 3 105: Class 2 Device Recall Philips HeartStart (HS1) (Onsite/Home) AED 101
  • Figure 3 106: Class 3 Device Recall XL Defibrillator 102
  • Figure 3 107: Class 2 Device Recall Philips QCPR Meter CPR feedback device 102
  • Figure 3 108: Class 2 Device Recall HeartStart MRx Monitor/Defibrillator 102
  • Figure 3 109: Class 2 Device Recall Philips HeartStart 102
  • Figure 3 110: Class 2 Device Recall BW Lasso 2515 ANV eco Variable Diagnostic EP Catheter 103
  • Figure 3 111: Class 2 Device Recall Reprocessed LASSO NAV eco Electrophysiology Catheter 103
  • Figure 3 112: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter 103
  • Figure 3 113: Class 2 Device Recall Stryker Sustainability Solutions Reprocessed BW Lasso 2515 NAV eco Variable Diagnostic 104
  • Figure 3 114: Class 2 Device Recall Stryker Sustainability Solutions 104
  • Figure 3 115: Class 2 Device Recall Daig Livewire Steerable and Supreme Fixed Curve Diagnostic Electrophysiology Catheters 104
  • Figure 3 116: Class 2 Class 2 Device Recall OneStep CPR Complete 105
  • Figure 3 117: Class 2 Device Recall LifeVest Wearable Defibrillator 105
  • Figure 3 118: SJM Brady MRI Post Approval Study 106
  • Figure 3 119: Evaluation of Atrial Fibrillation Occurrence in Sick Sinus and Complete Atrioventricular Block Patients After Pacemaker Implantation (AF-pacemaker Study) 107
  • Figure 3 120: Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers 107
  • Figure 3 121: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan 107
  • Figure 3 122: BIO|MASTER.Edora Family Study 108
  • Figure 3 123: China Micra Transcatheter Pacing Study 108
  • Figure 3 124: Optimizing Pacemaker Therapy Using Multi-Point Pacing (the OPT-MPP Study) 108
  • Figure 3 125: Cardioversion, Ablation or Pace and Ablate for Persistent Atrial Fibrillation in Over 65s - The CAPAPAF-65 Study 109
  • Figure 3 126: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes II 109
  • Figure 3 127: Observation of ImageReady™ MR Conditional Pacing System in China 109
  • Figure 3 128: Micra Transcatheter Pacing System Continued Access Study Protocol 110
  • Figure 3 129: Comparison of CRT-D and CRT-DX Systems (CRT-NEXT) 110
  • Figure 3 130: Increasing Detection of Sub-Clinical Atrial Fibrillation in Defibrillator Patients with the Use of a VDD-ICD Lead (Dx-AF) 111
  • Figure 3 131: Multicenter Automatic Defibrillator Implantation Trial with Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD) 111
  • Figure 3 132: Extravascular ICD Pilot Study 111
  • Figure 3 133: Acute Feasibility Investigation of a New S-ICD Electrode Arrangement for Reduction of Defibrillation Energies 112
  • Figure 3 134: Subcutaneous ICD Therapy Combined with VT Ablation for the Secondary Prevention of Sudden Cardiac Death 112
  • Figure 3 135: BIO|MASTER.Ilivia Family/Plexa 112
  • Figure 3 136: The REACT-ICD Trial (REACT-ICD) 113
  • Figure 3 137: Prospective Randomized Trial Comparing TRIPLE Site ventricular Stimulation Versus Conventional Pacing in CRT candidates: TRIPLEAD Trial 113
  • Figure 3 138: Can Cognitive Function be Improved by Cardiac Resynchronization Therapy? (COGNI-CRT) 114
  • Figure 3 139: Re-evaluation of Optimal Re-synchronization Therapy in Patients with Chronic Heart Failure - An Investigator-driven, Prospective, Parallel-group, Randomized, Open, Blinded Outcome Assessment (PROBE), Multi-center Trial Without Investigational Medical Products (Proof of Strategy Trial) 114
  • Figure 3 140: Continued Access Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the Paradym RF SonR CRT-D 115
  • Figure 3 141: AV Optimization Delivered with Direct His Bundle Pacing, in Patients with Heart Failure, Long PR Without Left Bundle Branch Block: Randomized Multi-center Clinical Outcome Study. 115
  • Figure 3 142: Heart Failure with Preserved Ejection Fraction Treated by Cardiac Resynchronization Therapy Versus Rate Responsive Pacing: A Mechanistic Study 116
  • Figure 3 143: Cardiac Resynchronization in the Elderly: Piloting Pacemaker vs. Defibrillator Therapy (Randomized Trial) 116
  • Figure 3 144: Assessment of Pacing Stimulus Conduction and Latency Measurements in CRT-D Patients (BIO|PULSE) 116
  • Figure 3 145: A Multicentre Randomized Control Trial Comparing Standard Cardiac Resynchronization Pacing with Triventricular Pacing 117
  • Figure 3 146: Responders and Quadripolar LV Lead in CRT 117
  • Figure 3 147: Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalization for Heart Failure (HF)" in Patients with HF and Prolonged QRS 118
  • Figure 3 148: Plexa ICD Lead Registry 118
  • Figure 3 149: AXONE -Acute: Safety and Electrical Performance Evaluation of INVICTA Leads Models Equipped with DF4 Connector 119
  • Figure 3 150: Safety and Electrical Performances Evaluation of Navigo Leads Equipped with IS4 Connector (NAVIGATOR) 119
  • Figure 3 151: Avoid Transvenous Leads in Appropriate Subjects 120
  • Figure 3 152: Left Ventricular Septal Pacing: Potential Application for Cardiac Resynchronization Therapy 120
  • Figure 3 153: Quartet Lead and Resynchronization Therapy Options - Assessing the Response Rate at 6 Months in CRT Patients Implanted with a Quartet Left Ventricular (LV) Quadripolar Lead and the MultiPoint Pacing (MPP) Feature Activated 121
  • Figure 3 154: Attain Stability™ Quad Clinical Study 121
  • Figure 3 155: Imaging Study of Lead Implant for His Bundle Pacing ((IMAGE-HBP)) 122
  • Figure 3 156: The Efficacy of Single Coil Defibrillation Leads for Internal Cardioversion of Persistent Atrial Fibrillation 122
  • Figure 3 157: Reverse RAMP Pacing to Terminate Ventricular Tachycardia (REV-RAMP) 122
  • Figure 3 158: AXONE -Acute: Acute Assessment of a Micro Multipolar Lead for Enhanced Cardiac Resynchronization Therapy 123
  • Figure 3 159: A Clinical Evaluation of the Durata or Optisure High Voltage Leads and Ellipse VR ICD Undergoing Magnetic Resonance Imaging, an Investigational Device Exemption (IDE) Study 123
  • Figure 3 160: Acute Extravascular Defibrillation Study 123
  • Figure 3 161: Quality of Cardiopulmonary Resuscitation Guided by AED vs Telephone-assistance 124
  • Figure 3 162: Accuracy of Instructional Diagrams for Automated External Defibrillator (AED) Pad Positioning 124
  • Figure 3 163: RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY) 125
  • Figure 3 164: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter 125
  • Figure 3 165: Real-time Electrogram Analysis for Drivers of AtRial Fibrillation (RADAR) 126
  • Figure 3 166: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia 126
  • Figure 3 167: Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias 127
  • Figure 3 168: Surface ECG Signal Recording for the Implantable Subcutaneous String Defibrillator (ISSD) Detection Algorithm Performance Assessment 127
  • Figure 3 169: Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development 128
  • Figure 3 170: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 128
  • Figure 3 171: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System 129
  • Figure 3 172: INtra-procedural ultraSound Imaging for DEtermination of Atrial Wall Thickness and Acute Tissue Changes During Isolation of the Pulmonary Veins 129
  • Figure 3 173: EnSite Precision™ Cardiac Mapping System and EnSite Precision™ Software v2.0 Observational Registry 130
  • Figure 3 174: Visualization of Human Cardiovascular Anatomy With Foresight Intracardiac Echocardiography (ICE) System 130
  • Figure 3 175: Esophageal 3D Mapping System for Cardiac Arrhythmias: Pilot Study to Establish Basis for Improved Arrhythmia Diagnostics Using the esoECG-3D Catheter 131
  • Figure 3 176: EnSite™ HD Grid Catheter Mapping System for Advanced High Density Three-Dimensional Mapping in Non-Paroxysmal Atrial Fibrillation and Atrial Tachycardia 131
  • Figure 3 177: DURABLE-I Study: Dielectric Unravelling of Radiofrequency ABLation Effectiveness 132
  • Figure 3 178: FIRE AND ICE II Trial Pilot 133
  • Figure 3 179: Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR) 133
  • Figure 3 180: Clinical Study for Safety and Acute Performance Evaluation of the THERMOCOOL SMARTTOUCH® SF-5D System Used With Fast Ablation Mode in Treatment of Patients With Paroxysmal Atrial Fibrillation 134
  • Figure 3 181: Microfidelity (MIFI) Ablation Technology Versus Standard Ablation Catheter for Atrioventricular Nodal Ablation A Comparative Pilot Study of Time to Success 134
  • Figure 3 182: Cardiovascular Magnetic Resonance-Guided Radiofrequency-Ablation for Atrial Flutter 135
  • Figure 3 183: Advanced Cardiac Therapeutics DiamondTemp TempeRAture-Controlled and Contact Sensing RF Ablation Clinical Trial for Atrial Fibrillation 135
  • Figure 3 184: Feasibility Study for Optically Guided Radiofrequency Ablation Catheter 135
  • Figure 3 185: CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial 136
  • Figure 3 186: Cryoballoon Pulmonary Vein Isolation as First Line Treatment for Typical Atrial Flutter 136
  • Figure 3 187: ArcticLine Feasibility Study 136
  • Figure 3 188: A Prospective, Multicenter Investigation of the Adagio Cryoablation System in Patients With Atrial Fibrillation 137
  • Figure 3 189: A Prospective Study of Medical Therapy Against Cryoballoon Ablation in Symptomatic Recent Onset Persistent Atrial Fibrilation 137
  • Figure 3 190: STOP AF First: Cryoballoon Catheter Ablation in an Antiarrhythmic Drug Naive Paroxysmal Atrial Fibrillation 138
  • Figure 3 191: CoolLoop Paroxysmal Atrial Fibrillation 138
  • Figure 3 192: A Comparison of Radiofrequency Catheter Ablation With or Without Contact-force and Cryoablation for Paroxysmal Atrial Fibrillation Ablation 139
  • Figure 3 193: A Prospective, Multicenter, Investigation of the Adagio PolarStar System in Subjects With Atrial Flutter 139
  • Figure 3 194: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) 140
  • Figure 3 195: Left Atrial Cryoablation Enhanced by Ganglionated Plexi Ablation in the Treatment of Atrial Fibrillation 140
  • Figure 3 196: Cryterion Cardiac Cryoablation System First in Man Clinical Study 141
  • Figure 3 197: STOP Persistent AF 141
  • Figure 3 198: Cryoablation of Atrial Fibrillation in Patients With Severe Heart Failure 141
  • Figure 3 199: PV Cryoablation Efficacy Using Electrophysiological Endpoints and the New Generation ArticFont Advance ST Catheter (COR ADVANCE Study) 142
  • Figure 3 200: CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation 142
  • Figure 3 201: Laser Ablation Study for trEatment of atRial Fibrillation (LASER) 143
  • Figure 3 202: A Clinical Trial for the Assessment of the Safety and Performance of the Vimecon Laser Cardiac Ablation Instrument (CAI) for the Interventional Treatment of Paroxysmal Atrial Fibrillation (AF) 143
  • Figure 4 1: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025 (US$M) (1 of 2) 147
  • Figure 4 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market by Segment, U.S., 2015 - 2025 (US$M) (2 of 2) 148
  • Figure 4 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 - 2025 (1 of 2) 153
  • Figure 4 4: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market Growth by Segment, U.S., 2015 - 2025 (2 of 2) 154
  • Figure 4 5: Drivers and Limiters, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 160
  • Figure 4 6: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (1 of 2) 164
  • Figure 4 7: Leading Competitors, Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Market, U.S., 2018 (2 of 2) 165
  • Figure 4 8: SWOT Analysis, Abbott (1 of 2) 179
  • Figure 4 9: SWOT Analysis, Abbott (2 of 2) 180
  • Figure 4 10: SWOT Analysis, Biosense Webster 181
  • Figure 4 11: SWOT Analysis, Biotronik 182
  • Figure 4 12: SWOT Analysis, Boston Scientific 183
  • Figure 4 13: SWOT Analysis, Cardiac Science 184
  • Figure 4 14: SWOT Analysis, GE Healthcare 185
  • Figure 4 15: SWOT Analysis, Medtronic 186
  • Figure 4 16: SWOT Analysis, MicroPort (1 of 2) 187
  • Figure 4 17: SWOT Analysis, MicroPort (2 of 2) 188
  • Figure 4 18: SWOT Analysis, ZOLL 189
  • Figure 5 1: Procedure Codes Investigated, U.S., 2018 190
  • Figure 5 2: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 - 2025 (1 of 2) 191
  • Figure 5 3: Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures by Type, U.S., 2015 - 2025 (2 of 2) 192
  • Figure 6 1: Pacemaker Market by Segment, U.S., 2015 - 2025 (US$M) 198
  • Figure 6 2: Total Pacemaker Market, U.S., 2015 - 2025 202
  • Figure 6 3: Single-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025 (US$M) 205
  • Figure 6 4: Total Single-Chamber Pacemaker Market, U.S., 2015 - 2025 207
  • Figure 6 5: Initial Placement Single-Chamber Pacemaker Market, U.S., 2015 - 2025 209
  • Figure 6 6: Replacement Single-Chamber Pacemaker Market, U.S., 2015 - 2025 211
  • Figure 6 7: Dual-Chamber Pacemaker Market by Segment, U.S., 2015 - 2025 (US$M) 214
  • Figure 6 8: Total Dual-Chamber Pacemaker Market, U.S., 2015 - 2025 216
  • Figure 6 9: Initial Placement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025 218
  • Figure 6 10: Replacement Dual-Chamber Pacemaker Market, U.S., 2015 - 2025 220
  • Figure 6 11: Leadless Pacemaker Market, U.S., 2015 - 2025 223
  • Figure 6 12: Pricing Tiers, Pacemaker Market, U.S., 2018 225
  • Figure 6 13: Drivers and Limiters, Pacemaker Market, U.S., 2018 228
  • Figure 6 14: Leading Competitors, Pacemaker Market, U.S., 2018 231
  • Figure 7 1: ICD Market by Segment, U.S., 2015 - 2025 (US$M) 235
  • Figure 7 2: Total ICD Market, U.S., 2015 - 2025 239
  • Figure 7 3: Single-Chamber ICD Market by Segment, U.S., 2015 - 2025 (US$M) 242
  • Figure 7 4: Total Single-Chamber ICD Market, U.S., 2015 - 2025 244
  • Figure 7 5: Initial Placement Single-Chamber ICD Market, U.S., 2015 - 2025 246
  • Figure 7 6: Replacement Single-Chamber ICD Market, U.S., 2015 - 2025 248
  • Figure 7 7: Dual-Chamber ICD Market by Segment, U.S., 2015 - 2025 (US$M) 251
  • Figure 7 8: Total Dual-Chamber ICD Market, U.S., 2015 - 2025 253
  • Figure 7 9: Initial Placement Dual-Chamber ICD Market, U.S., 2015 - 2025 255
  • Figure 7 10: Replacement Dual-Chamber ICD Market, U.S., 2015 - 2025 257
  • Figure 7 11: S-ICD Market, U.S., 2015 - 2025 260
  • Figure 7 12: Drivers and Limiters, ICD Market, U.S., 2018 264
  • Figure 7 13: Leading Competitors, ICD Market, U.S., 2018 267
  • Figure 8 1: Cardiac Resynchronization Therapy Device Market by Segment, U.S., 2015 - 2025 (US$M) 271
  • Figure 8 2: Total CRT Market, U.S., 2015 - 2025 276
  • Figure 8 3: CRT-P Market by Segment, U.S., 2015 - 2025 (US$M) 278
  • Figure 8 4: Total CRT-P Market, U.S., 2015 - 2025 280
  • Figure 8 5: Initial Placement CRT-P Market, U.S., 2015 - 2025 282
  • Figure 8 6: Replacement CRT-P Market, U.S., 2015 - 2025 284
  • Figure 8 7: CRT-D Market by Segment, U.S., 2015 - 2025 (US$M) 286
  • Figure 8 8: Total CRT-D Market, U.S., 2015 - 2025 288
  • Figure 8 9: Initial Placement CRT-D Market, U.S., 2015 - 2025 290
  • Figure 8 10: Replacement CRT-D Market, U.S., 2015 - 2025 292
  • Figure 8 11: Drivers and Limiters, CRT Market, U.S., 2018 297
  • Figure 8 12: Leading Competitors, CRT Market, U.S., 2018 300
  • Figure 9 1: Cardiac Lead Market by Segment, U.S., 2015 - 2025 (US$M) 304
  • Figure 9 2: Total Cardiac Lead Market, U.S., 2015 - 2025 308
  • Figure 9 3: Pacing Lead Market, U.S., 2015 - 2025 310
  • Figure 9 4: Defibrillation Lead Market, U.S., 2015 - 2025 312
  • Figure 9 5: LV Lead Market, U.S., 2015 - 2025 314
  • Figure 9 6: Drivers and Limiters, Cardiac Lead Market, U.S., 2018 318
  • Figure 9 7: Leading Competitors, Cardiac Lead Market, U.S., 2018 321
  • Figure 10 1: Electrocardiography Monitoring Market by Segment, U.S., 2015 - 2025 (US$M) 325
  • Figure 10 2: Resting ECG Device Market by Segment, U.S., 2015 - 2025 (US$M) 329
  • Figure 10 3: Total Resting ECG Device Market, U.S., 2015 - 2025 331
  • Figure 10 4: Hospital-Based Resting ECG Device Market, U.S., 2015 - 2025 333
  • Figure 10 5: Office-Based Resting ECG Device Market by Segment, U.S., 2015 - 2025 (US$M) 335
  • Figure 10 6: Total Office-Based Resting ECG Device Market, U.S., 2015 - 2025 337
  • Figure 10 7: Purpose-Built Office-Based Resting ECG Device Market, U.S., 2015 - 2025 339
  • Figure 10 8: PC-Based Office-Based Resting ECG Device Market, U.S., 2015 - 2025 341
  • Figure 10 9: Stress Testing Device Market by Segment, U.S., 2015 - 2025 (US$M) 344
  • Figure 10 10: Total Stress Testing Device Market, U.S., 2015 - 2025 346
  • Figure 10 11: Hospital-Based Stress Testing Device Market, U.S., 2015 - 2025 348
  • Figure 10 12: Office-Based Stress Testing Device Market, U.S., 2015 - 2025 350
  • Figure 10 13: Holter Monitoring Recorder Market by Segment, U.S., 2015 - 2025 (US$M) 353
  • Figure 10 14: Total Holter Monitoring Recorder Market, U.S., 2015 - 2025 355
  • Figure 10 15: Hospital-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025 357
  • Figure 10 16: Office-Based Holter Monitoring Recorder Market, U.S., 2015 - 2025 359
  • Figure 10 17: IDTF Holter Monitoring Recorder Market, U.S., 2015 - 2025 361
  • Figure 10 18: Drivers and Limiters, Electrocardiography Monitoring Market, U.S., 2018 365
  • Figure 10 19: Leading Competitors, Electrocardiography Monitoring Market, U.S., 2018 368
  • Figure 11 1: Lab Systems Market by Segment, U.S., 2015 - 2025 (US$M) 373
  • Figure 11 2: 3D Mapping Market, U.S., 2015 - 2025 377
  • Figure 11 3: EP Recording Market, U.S., 2015 - 2025 379
  • Figure 11 4: RF Ablation Generator Market, U.S., 2015 - 2025 381
  • Figure 11 5: Remote Steering System Market, U.S., 2015 - 2025 383
  • Figure 11 6: Drivers and Limiters, Lab Systems Market, U.S., 2018 387
  • Figure 11 7: Leading Competitors, Lab Systems Market, U.S., 2018 (1 of 2) 390
  • Figure 12 1: Diagnostic Electrophysiology Catheters Market by Segment, U.S., 2015 - 2025 (US$M) 394
  • Figure 12 2: Total Diagnostic Electrophysiology Catheters Market, U.S., 2015 - 2025 399
  • Figure 12 3: EP Conventional Catheter Market by Segment, U.S., 2015 - 2025 (US$M) 402
  • Figure 12 4: Total EP Conventional Catheter Market, U.S., 2015 - 2025 404
  • Figure 12 5: Fixed EP Catheter Market, U.S., 2015 - 2025 406
  • Figure 12 6: Steerable EP Catheter Market, U.S., 2015 - 2025 408
  • Figure 12 7: EP Advanced Catheter Market, U.S., 2015 - 2025 410
  • Figure 12 8: ICE Diagnostic Catheter Market, U.S., 2015 - 2025 413
  • Figure 12 9: Drivers and Limiters, Diagnostic Electrophysiology Catheters Market, U.S., 2018 417
  • Figure 12 10: Leading Competitors, Diagnostic Electrophysiology Catheters Market, U.S., 2018 420
  • Figure 13 1: Cardiac Ablation Catheter Market by Segment, U.S., 2015 - 2025 (US$M) 424
  • Figure 13 2: Cardiac Ablation Catheter Market, U.S., 2015 - 2025 428
  • Figure 13 3: RF Ablation Catheter Market by Segment, U.S., 2015 - 2025 (US$M) 431
  • Figure 13 4: Total RF Ablation Catheter Market, U.S., 2015 - 2025 433
  • Figure 13 5: Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025 435
  • Figure 13 6: Non-Irrigated RF Ablation Catheter Market, U.S., 2015 - 2025 437
  • Figure 13 7: Cryoablation Catheter Market, U.S., 2015 - 2025 439
  • Figure 13 8: Drivers and Limiters, Cardiac Ablation Catheter Market, U.S., 2018 443
  • Figure 13 9: Leading Competitors, Cardiac Ablation Catheter Market, U.S., 2018 446
  • Figure 14 1: ICE Generator Market, U.S., 2015 - 2025 449
  • Figure 14 2: Drivers and Limiters, ICE Generator Market, U.S., 2018 453
  • Figure 14 3: Leading Competitors, ICE Generator Market, U.S., 2018 455
  • Figure 15 1: Cryoablation Generator Market, U.S., 2015 - 2025 458
  • Figure 15 2: Drivers and Limiters, Cryoablation Generator Market, U.S., 2018 462
  • Figure 16 1: External Defibrillator Market by Segment, U.S., 2015 - 2025 (US$M) 467
  • Figure 16 2: Total External Defibrillator Market, U.S., 2015 - 2025 472
  • Figure 16 3: Automated External Defibrillator Market, U.S., 2015 - 2025 474
  • Figure 16 4: Wearable Cardioverter Defibrillator Market, U.S., 2015 - 2025 476
  • Figure 16 5: Drivers and Limiters, External Defibrillator Market, U.S., 2018 480
  • Figure 16 6: Leading Competitors, External Defibrillator Market, U.S., 2018 482
目次
Product Code: iDATA_USCRMEP19_MS

This report on cardiac rhythm management (CRM) devices analyzes the market for medical devices used for diagnosing and treating cardiac arrhythmias. The medical device markets included in this report are pacemakers, implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy devices (CRTs), cardiac stimulation leads, electrocardiogram monitoring (ECGs), external defibrillators, electrophysiology (EP) lab systems, diagnostic electrophysiology (EP) catheters and cardiac ablation catheters.

In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the forecast period, the market will maintain growth at a CAGR in the mid single digits.

TABLE OF CONTENTS

TABLE OF CONTENTS I

LIST OF FIGURES XIII

LIST OF CHARTS XXVII

EXECUTIVE SUMMARY 1

U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 1

COMPETITIVE ANALYSIS 4

MARKET TRENDS 7

MARKET DEVELOPMENTS 9

PROCEDURE NUMBERS 12

PROCEDURE CODES INVESTIGATED 12

MARKETS INCLUDED 13

KEY REPORT UPDATES 15

VERSION HISTORY 15

RESEARCH METHODOLOGY 16

  • Step 1: Project Initiation & Team Selection 16
  • Step 2: Prepare Data Systems and Perform Secondary Research 19
  • Step 3: Preparation for Interviews & Questionnaire Design 21
  • Step 4: Performing Primary Research 22
  • Step 5: Research Analysis: Establishing Baseline Estimates 24
  • Step 6: Market Forecast and Analysis 25
  • Step 7: Identify Strategic Opportunities 27
  • Step 8: Final Review and Market Release 28
  • Step 9: Customer Feedback and Market Monitoring 29

DISEASE OVERVIEW 30

  • 2.1 INTRODUCTION 30
  • 2.2 TYPES OF ARRHYTHMIAS 31
    • 2.2.11 Atrial Fibrillation 31
    • 2.2.12 Bradycardia 32
    • 2.2.13 Conduction Disorders 32
      • 2.2.13.1 Bundle Branch Block 32
      • 2.2.13.2 Heart Block 33
      • 2.2.13.3 Long QT Syndrome (LQTS) 34
    • 2.2.14 Premature Contractions: PACs and PVCs 34
    • 2.2.15 Tachycardia 35
    • 2.2.16 Ventricular Fibrillation 36
    • 2.2.17 Other Rhythm Disorders 36
      • 2.2.17.1 Adams-Stokes Disease 36
      • 2.2.17.2 Atrial Flutter 37
      • 2.2.17.3 Sick Sinus syndrome 37
      • 2.2.17.4 Sinus Arrhythmia 37
      • 2.2.17.5 Wolff-Parkinson-White Syndrome (WPW) 37
    • 2.2.18 Types of Arrhythmia in Children 37
  • 2.3 HEART FAILURE 38
  • 2.4 CARDIAC ARREST 39
  • 2.5 PATIENT DEMOGRAPHICS 40
    • 2.5.11 Atrial Fibrillation 40
    • 2.5.12 Bradycardia 40
    • 2.5.13 Conduction Disorders 41
    • 2.5.14 Premature Contractions - PACs and PVCs 42
    • 2.5.15 Tachycardia 43
    • 2.5.16 Ventricular Fibrillation 43
    • 2.5.17 Other Rhythm Disorders 44

PRODUCT ASSESSMENT 45

  • 3.1 INTRODUCTION 45
  • 3.2 PRODUCT PORTFOLIOS 45
    • 3.2.1 Pacemakers 45
    • 3.2.2 Implantable Cardioverter Defibrillators (ICDs) 48
    • 3.2.3 Cardiac Resynchronization Therapy (CRT) Devices 50
    • 3.2.4 Cardiac Leads 52
    • 3.2.5 External Defibrillators 54
    • 3.2.6 Lab Systems 56
      • 3.2.6.1 Introduction 56
      • 3.2.6.2 3D Mapping Systems 56
      • 3.2.6.3 EP Recording Systems 57
      • 3.2.6.4 Remote Steering Systems 58
      • 3.2.6.5 RF Ablation Generator 58
      • 3.2.6.6 ICE Systems 58
      • 3.2.6.7 Product Matrix for Lab Systems: Core Companies 60
    • 3.2.7 Diagnostic EP Catheters 61
      • 3.2.7.1 Introduction 61
      • 3.2.7.2 Diagnostic EP Catheters 61
      • 3.2.7.3 ICE Catheters 62
    • 3.2.8 Cardiac Ablation Catheters 65
      • 3.2.8.1 Introduction 65
      • 3.2.8.2 RF Ablation Catheters 66
      • 3.2.8.3 Alternative Energy Catheters 67
      • 3.2.8.4 High Intensity Focused Ultrasound 67
  • 3.3 FDA RECALLS 70
    • 3.3.1 Abbott 70
      • 3.3.1.1 Pacemakers 70
      • 3.3.1.2 Implantable Cardioverter Defibrillators (ICDs) 71
      • 3.3.1.3 Cardiac Resynchronization Therapy (CRT) Devices 72
      • 3.3.1.4 Cardiac Leads 73
      • 3.3.1.5 EP Lab Devices 73
      • 3.3.1.6 Cardiac Ablation Catheter 74
    • 3.3.2 Biosense Webster 75
      • 3.3.2.1 EP Lab Devices 75
    • 3.3.3 Boston Scientific 76
      • 3.3.3.1 Pacemakers 76
      • 3.3.3.2 Implantable Cardioverter Defibrillators (ICDs) 82
      • 3.3.3.3 Cardiac Resynchronization Therapy (CRT) Devices 83
      • 3.3.3.4 Cardiac Leads 86
      • 3.3.3.5 EP Lab Devices 86
      • 3.3.3.6 RF Ablation Catheter 87
    • 3.3.4 Cardiac Science 88
      • 3.3.4.1 Automated External Defibrillator (AED) 88
    • 3.3.5 Medtronic 89
      • 3.3.5.1 Pacemakers 89
      • 3.3.5.2 Implantable Cardioverter Defibrillators (ICDs) 90
      • 3.3.5.3 Cardiac Resynchronization Therapy (CRT) Devices 93
      • 3.3.5.4 Cardiac Leads 96
      • 3.3.5.5 EP Lab Devices 96
    • 3.3.6 MicroPort 97
      • 3.3.6.1 Implantable Cardioverter Defibrillators (ICDs) 97
      • 3.3.6.2 Cardiac Resynchronization Therapy (CRT) Devices 99
    • 3.3.7 Philips Healthcare 101
      • 3.3.7.1 Automated External Defibrillator (AED) 101
    • 3.3.8 Stryker Sustainability Solutions 103
      • 3.3.8.1 Diagnostic EP Catheters 103
    • 3.3.9 ZOLL 105
      • 3.3.9.1 Automated External Defibrillator (AED) 105
      • 3.3.9.2 Wearable Cardioverter Defibrillator (WCD) 105
  • 3.4 CLINICAL TRIALS 106
    • 3.4.1 Pacemakers 106
    • 3.4.2 Implantable Cardioverter Defibrillators (ICDs) 110
    • 3.4.3 Cardiac Resynchronization Therapy (CRT) Devices 113
    • 3.4.4 Cardiac Leads 118
    • 3.4.5 External Defibrillators 124
    • 3.4.6 Lab Systems 125
      • 3.4.6.1 3D Mapping Systems 125
      • 3.4.6.2 EP Recording Systems 127
      • 3.4.6.3 RF Ablation Generators 128
      • 3.4.6.4 ICE Systems 129
    • 3.4.7 Diagnostic EP Catheters 131
      • 3.4.7.1 Diagnostic Catheter 131
    • 3.4.8 Cardiac Ablation Catheter 133
      • 3.4.8.1 RF Ablation Catheters 133
      • 3.4.8.2 Cryoablation Catheters 136
      • 3.4.8.3 Laser Ablation Catheters 142

U.S. CARDIAC RHYTHM MANAGEMENT, ELECTROPHYSIOLOGY & CARDIAC ABLATION MARKET OVERVIEW 144

  • 4.1 INTRODUCTION 144
  • 4.2 MARKET OVERVIEW 146
  • 4.3 TREND ANALYSIS BY SEGMENT 152
  • 4.4 DRIVERS AND LIMITERS 156
    • 4.4.1 Market Drivers 156
    • 4.4.2 Market Limiters 157
  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS 161
  • 4.6 MERGERS AND ACQUISITIONS 167
  • 4.7 COMPANY PROFILES 168
    • 4.7.1 Abbott 168
    • 4.7.2 Biosense Webster 169
    • 4.7.3 Biotronik 170
    • 4.7.4 Boston Scientific 171
    • 4.7.5 Cardiac Science 173
    • 4.7.6 GE Healthcare 174
    • 4.7.7 Medtronic 175
    • 4.7.8 MicroPort 176
    • 4.7.9 ZOLL 178
  • 4.8 SWOT ANALYSIS 179
    • 4.8.1 Abbott 179
    • 4.8.2 Biosense Webster 181
    • 4.8.3 Biotronik 182
    • 4.8.4 Boston Scientific 183
    • 4.8.5 Cardiac Science 184
    • 4.8.6 GE Healthcare 185
    • 4.8.7 Medtronic 186
    • 4.8.8 MicroPort 187
    • 4.8.9 ZOLL 189

PROCEDURE NUMBERS 190

  • 5.1 INTRODUCTION 190
  • 5.2 PROCEDURES 191
    • 5.2.1 Total Cardiac Rhythm Management, Electrophysiology & Cardiac Ablation Procedures 191

PACEMAKER MARKET 194

  • 6.1 INTRODUCTION 194
    • 6.1.1 Single and Dual-Chamber Devices 194
    • 6.1.2 MRI-Compatible Pacemaker 195
    • 6.1.3 Leadless Pacemaker 195
    • 6.1.4 Initial Placement and Replacement of Pacemakers 196
  • 6.2 MARKET OVERVIEW 197
  • 6.3 MARKET ANALYSIS AND FORECAST 202
    • 6.3.1 Total Pacemaker Market 202
    • 6.3.2 Total Single-Chamber Pacemaker Market 204
      • 6.3.2.1 Initial Placement Single-Chamber Pacemaker Market 209
      • 6.3.2.2 Replacement Single-Chamber Pacemaker Market 211
    • 6.3.3 Total Dual-Chamber Pacemaker Market 213
      • 6.3.3.1 Initial Placement Dual-Chamber Pacemaker Market 218
      • 6.3.3.2 Replacement Dual-Chamber Pacemaker Market 220
    • 6.3.4 Leadless Pacemaker Market 222
  • 6.4 PRICE ANALYSIS 225
  • 6.5 DRIVERS AND LIMITERS 226
    • 6.5.1 Market Drivers 226
    • 6.5.2 Market Limiters 227
  • 6.6 COMPETITIVE MARKET SHARE ANALYSIS 229

IMPLANTABLE CARDIOVERTER DEFIBRILLATOR MARKET 233

  • 7.1 INTRODUCTION 233
  • 7.2 MARKET OVERVIEW 235
  • 7.3 MARKET ANALYSIS AND FORECAST 239
    • 7.3.1 Total ICD Market 239
    • 7.3.2 Total Single-Chamber ICD Market 241
      • 7.3.2.1 Initial Placement Single-Chamber ICD Market 246
      • 7.3.2.2 Replacement Single-Chamber ICD Market 248
    • 7.3.3 Total Dual-Chamber ICD Market 250
      • 7.3.3.1 Initial Placement Dual-Chamber ICD Market 255
      • 7.3.3.2 Replacement Dual-Chamber ICD Market 257
    • 7.3.4 S-ICD Market 259
  • 7.4 DRIVERS AND LIMITERS 262
    • 7.4.1 Market Drivers 262
    • 7.4.2 Market Limiters 263
  • 7.5 COMPETITIVE MARKET SHARE ANALYSIS 265

CARDIAC RESYNCHRONIZATION THERAPY DEVICE MARKET 269

  • 8.1 INTRODUCTION 269
    • 8.1.1 Cardiac Resynchronization Therapy-Pacemakers (CRT-Ps) 269
    • 8.1.2 Cardiac Resynchronization Therapy-Defibrillators (CRT-Ds) 269
  • 8.2 MARKET OVERVIEW 270
  • 8.3 MARKET ANALYSIS AND FORECAST 275
    • 8.3.1 Total CRT Market 275
    • 8.3.2 Total CRT-P Market 278
      • 8.3.2.1 Initial Placement CRT-P Market 282
      • 8.3.2.2 Replacement CRT-P Market 284
    • 8.3.3 Total CRT-D Market 286
      • 8.3.3.1 Initial Placement CRT-D Market 290
      • 8.3.3.2 Replacement CRT-D Market 292
  • 8.4 DRIVERS AND LIMITERS 294
    • 8.4.1 Market Drivers 294
    • 8.4.2 Market Limiters 295
  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS 298

CARDIAC LEADS MARKET 302

  • 9.1 INTRODUCTION 302
    • 9.1.1 Replacement of Leads 303
  • 9.2 MARKET OVERVIEW 304
  • 9.3 MARKET ANALYSIS AND FORECAST 308
    • 9.3.1 Total Cardiac Lead Market 308
    • 9.3.2 Pacing Lead Market 310
    • 9.3.3 Defibrillation Lead Market 312
    • 9.3.4 LV Lead Market 314
  • 9.4 DRIVERS AND LIMITERS 316
    • 9.4.1 Market Drivers 316
    • 9.4.2 Market Limiters 317
  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS 319

ELECTROCARDIOGRAPHY MONITORING MARKET 323

  • 10.1 INTRODUCTION 323
    • 10.1.1 Holter Monitoring 324
    • 10.1.2 Stress Testing 324
  • 10.2 MARKET OVERVIEW 325
  • 10.3 MARKET ANALYSIS AND FORECAST 329
    • 10.3.1 Total Resting ECG Device Market 329
      • 10.3.1.1 Hospital-Based Resting ECG Device Market 333
      • 10.3.1.2 Total Office-Based Resting ECG Device Market 335
      • 10.3.1.2.1 Purpose-Built Office-Based Resting ECG Device Market 339
      • 10.3.1.2.2 PC-Based Office-Based Resting ECG Device Market 341
    • 10.3.2 Total Stress Testing Device Market 343
      • 10.3.2.1 Hospital-Based Stress Testing Device Market 348
      • 10.3.2.2 Office-Based Stress Testing Device Market 350
    • 10.3.3 Total Holter Monitoring Recorder Market 352
      • 10.3.3.1 Hospital-Based Holter Monitoring Recorder Market 357
      • 10.3.3.2 Office-Based Holter Monitoring Recorder Market 359
      • 10.3.3.3 IDTF Holter Monitoring Recorder Market 361
  • 10.4 DRIVERS AND LIMITERS 363
    • 10.4.1 Market Drivers 363
    • 10.4.2 Market Limiters 364
  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS 366

LAB SYSTEMS MARKET 370

  • 11.1 INTRODUCTION 370
    • 11.1.1 3D Mapping Systems 370
    • 11.1.2 EP Recording Systems 371
    • 11.1.3 Remote Steering Systems 371
    • 11.1.4 RF Ablation Generator 371
    • 11.1.5 ICE System 372
  • 11.2 MARKET OVERVIEW 373
  • 11.3 MARKET ANALYSIS AND FORECAST 377
    • 11.3.1 3D Mapping Market 377
    • 11.3.2 EP Recording Market 379
    • 11.3.3 RF Ablation Generator Market 381
    • 11.3.4 Remote Steering System Market 383
  • 11.4 DRIVERS AND LIMITERS 385
    • 11.4.1 Market Drivers 385
    • 11.4.2 Market Limiters 386
  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS 388

DIAGNOSTIC ELECTROPHYSIOLOGY CATHETERS MARKET 392

  • 12.1 INTRODUCTION 392
    • 12.1.1 Diagnostic Electrophysiology Catheters 392
    • 12.1.2 Reprocessed Catheters 393
    • 12.1.3 Intracardiac Echocardiography 393
  • 12.2 MARKET OVERVIEW 394
  • 12.3 MARKET ANALYSIS AND FORECAST 398
    • 12.3.1 Total Diagnostic Electrophysiology Catheters Market 398
    • 12.3.2 Total EP Conventional Catheter Market 401
      • 12.3.2.1 Fixed EP Catheter Market 406
      • 12.3.2.2 Steerable EP Catheter Market 408
    • 12.3.3 EP Advanced Catheter Market 410
    • 12.3.4 ICE Diagnostic Catheter Market 412
  • 12.4 DRIVERS AND LIMITERS 415
    • 12.4.1 Market Drivers 415
    • 12.4.2 Market Limiters 416
  • 12.5 COMPETITIVE MARKET SHARE ANALYSIS 418

CARDIAC ABLATION CATHETER MARKET 422

  • 13.1 INTRODUCTION 422
  • 13.2 MARKET OVERVIEW 424
  • 13.3 MARKET ANALYSIS AND FORECAST 428
    • 13.3.1 Cardiac Ablation Catheter Market 428
    • 13.3.2 RF Ablation Catheter Market 430
      • 13.3.2.1 Irrigated RF Ablation Catheter Market 435
      • 13.3.2.2 Non-Irrigated RF Ablation Catheter Market 437
    • 13.3.3 Cryoablation Catheter Market 439
  • 13.4 DRIVERS AND LIMITERS 441
    • 13.4.1 Market Drivers 441
    • 13.4.2 Market Limiters 442
  • 13.5 COMPETITIVE MARKET SHARE ANALYSIS 444

APPENDIX I: INTRACARDIAC ECHOCARDIOGRAPHY (ICE) GENERATOR MARKET 448

  • 14.1 INTRODUCTION 448
  • 14.2 MARKET ANALYSIS AND FORECAST 449
  • 14.3 DRIVERS AND LIMITERS 451
    • 14.3.1 Market Drivers 451
    • 14.3.2 Market Limiters 452
  • 14.4 COMPETITIVE MARKET SHARE ANALYSIS 454

APPENDIX II: CRYOABLATION GENERATOR MARKET 457

  • 15.1 INTRODUCTION 457
  • 15.2 MARKET ANALYSIS AND FORECAST 458
  • 15.3 DRIVERS AND LIMITERS 460
    • 15.3.1 Market Drivers 460
    • 15.3.2 Market Limiters 461
  • 15.4 COMPETITIVE MARKET SHARE ANALYSIS 463

APPENDIX III: EXTERNAL DEFIBRILLATOR MARKET 464

  • 16.1 INTRODUCTION 464
    • 16.1.1 Automated External Defibrillator 464
    • 16.1.2 Wearable Cardioverter Defibrillator 464
  • 16.2 MARKET OVERVIEW 466
  • 16.3 MARKET ANALYSIS AND FORECAST 471
    • 16.3.1 Total External Defibrillator Market 471
    • 16.3.2 Automated External Defibrillator Market 474
    • 16.3.3 Wearable Cardioverter Defibrillator Market 476
  • 16.4 DRIVERS AND LIMITERS 478
    • 16.4.1 Market Drivers 478
    • 16.4.2 Market Limiters 479
  • 16.5 COMPETITIVE MARKET SHARE ANALYSIS 481

ABBREVIATIONS 484

Back to Top